April 29, 2026
Glossy sat down with Tally Health CEO Melanie Goldey to discuss the announcement of its acquisition by Infinite Epigenetics, parent company to TruDiagnostics, maker of tools to track one’s biological age, a metric popular among biohackers to measure efficacy of longevity protocols. The acquisition announcement is part of a larger shift across wellness businesses toward vertical integration.